Quality Investor

PCRX

Rank #87

Rank #87 by gross profitability (GP/assets 0.48) · ROE 1.1% · Piotroski F-Score N/A.

As-of 2026-07-22 · CIK 0001396814 · all metrics point-in-time as of the filing date.

Financials

Strengthening

Direction over 5 fiscal years

  • Free cash flowimproving
  • Gross marginstable
  • Gross profitabilitydeteriorating
  • Net cashimproving
  • Operating marginimproving
  • Return on equityimproving
  • Share count (dilution)improving

Monitoring diagnostic of business direction — not a prediction of returns.

Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.

USD in millions, except per-share (EPS) and percentage rows. Values are as originally filed; em-dash = not tagged in that year's filing.
Fiscal year end2021-12-31filed 2022-02-282020-12-31filed 2021-03-012019-12-31filed 2020-02-212018-12-31filed 2019-02-28
Income statement
Revenue541.5429.6421.0337.3
Revenue growth (YoY)26.0%2.0%24.8%17.7%
Gross profit401.3312.3314.3250.4
Gross margin74.1%72.7%74.7%74.3%
Net income42.0145.5(11.0)(0.5)
Net margin7.8%33.9%-2.6%-0.1%
EPS (diluted)$0.92$3.33
EPS growth (YoY)-72.4%
Cash flow
Operating cash flow125.777.070.548.9
Capital expenditures45.937.810.214.5
Free cash flow79.939.260.434.4

Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?